102 related articles for article (PubMed ID: 14756030)
1. [Limitations in the histopathologic diagnosis and prognosis of neuroblastoma].
Mihăilă D; Aprodu G; Ionescu C; Miron I; Maxim E; Plămădeală P
Rev Med Chir Soc Med Nat Iasi; 2003; 107(4):834-40. PubMed ID: 14756030
[TBL] [Abstract][Full Text] [Related]
2. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
Shimada H; Nakagawa A; Peters J; Wang H; Wakamatsu PK; Lukens JN; Matthay KK; Siegel SE; Seeger RC
Cancer; 2004 Oct; 101(8):1873-81. PubMed ID: 15386308
[TBL] [Abstract][Full Text] [Related]
3. Proliferation marker KI-S5 discriminates between favorable and adverse prognosis in advanced stages of neuroblastoma with and without MYCN amplification.
Krams M; Hero B; Berthold F; Parwaresch R; Harms D; Rudolph P
Cancer; 2002 Feb; 94(3):854-61. PubMed ID: 11857322
[TBL] [Abstract][Full Text] [Related]
4. [Value of prognostic factors in the Austrian A-NB87 Neuroblastoma Study].
Ladenstein R; Ambros PF; Urban C; Ambros IM; Fink FM; Zoubek A; Grienberger H; Schmitt K; Kerbl R; Horcher E; Amann G; Höfler G; Heinzl H; Gadner H; Mutz I
Klin Padiatr; 1996; 208(4):210-20. PubMed ID: 8926686
[TBL] [Abstract][Full Text] [Related]
5. [Prognosis of neuroblastoma in childhood. Methods of assessment and clinical use].
Pérel Y; Valteau-Couanet D; Michon J; Lavrand F; Coze C; Bergeron C; Notz A; Plantaz D; Chastagner P; Bernard F; Thomas C; Rubie H
Arch Pediatr; 2004 Jul; 11(7):834-42. PubMed ID: 15234382
[TBL] [Abstract][Full Text] [Related]
6. Neuroblastoma: biology, prognosis, and treatment.
Park JR; Eggert A; Caron H
Pediatr Clin North Am; 2008 Feb; 55(1):97-120, x. PubMed ID: 18242317
[TBL] [Abstract][Full Text] [Related]
7. Unequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma.
Vandesompele J; Baudis M; De Preter K; Van Roy N; Ambros P; Bown N; Brinkschmidt C; Christiansen H; Combaret V; Lastowska M; Nicholson J; O'Meara A; Plantaz D; Stallings R; Brichard B; Van den Broecke C; De Bie S; De Paepe A; Laureys G; Speleman F
J Clin Oncol; 2005 Apr; 23(10):2280-99. PubMed ID: 15800319
[TBL] [Abstract][Full Text] [Related]
8. [Therapeutic experience of childhood stage III neuroblastoma].
Ye QD; Tang JY; Pan C; Chen J; Xue HL; Chen J; Dong L; Zhou M; Shen SH
Zhonghua Yi Xue Za Zhi; 2010 Jun; 90(22):1556-8. PubMed ID: 20973238
[TBL] [Abstract][Full Text] [Related]
9. The RNA component of telomerase as a marker of biologic potential and clinical outcome in childhood neuroblastic tumors.
Maitra A; Yashima K; Rathi A; Timmons CF; Rogers BB; Shay JW; Gazdar AF
Cancer; 1999 Feb; 85(3):741-9. PubMed ID: 10091748
[TBL] [Abstract][Full Text] [Related]
10. [Tumor markers--personal experience. Ha-ras P21 in neuroblastoma: a new marker associating to patient's prognosis].
Tanaka T
Gan To Kagaku Ryoho; 1991 Jan; 18(1):143-50. PubMed ID: 1987897
[TBL] [Abstract][Full Text] [Related]
11. Neuroblastoma in the very young child: biological considerations.
Kemshead JT; Patel K; Phimister B
Br J Cancer Suppl; 1992 Aug; 18():S102-5. PubMed ID: 1503919
[TBL] [Abstract][Full Text] [Related]
12. MR imaging of neuroblastic masses.
Siegel MJ; Jaju A
Magn Reson Imaging Clin N Am; 2008 Aug; 16(3):499-513, vi. PubMed ID: 18585601
[TBL] [Abstract][Full Text] [Related]
13. Expression of type I interferon receptor and its relation with other prognostic factors in human neuroblastoma.
Mejía C; Navarro S; Colamonici OR; Pellín A; Castel V; Llombart-Bosch A
Oncol Rep; 1999; 6(1):149-53. PubMed ID: 9864419
[TBL] [Abstract][Full Text] [Related]
14. Ha-ras p21 in neuroblastoma: a new marker in prediction of patient outcome.
Tanaka T
Prog Clin Biol Res; 1994; 385():275-80. PubMed ID: 7972221
[No Abstract] [Full Text] [Related]
15. The prognostic significance of vanillylmandellic acid in neuroblastoma.
Aydin GB; Kutluk MT; Yalcin B; Varan A; Akyuz C; Buyukpamukcu M
Pediatr Hematol Oncol; 2010 Sep; 27(6):435-48. PubMed ID: 20578806
[TBL] [Abstract][Full Text] [Related]
16. [The use of neuron specific enolase in the prognosis and followup of neuroblastoma in children. Results of a retrospective series of 21 patients].
Abdennebi M; Boussen H; Harzallah L; Daldoul O; Ghanem A; Gamoudi A; Ben Slimene F; Rahal K; el May A; Ben Ayed F; Guemira F
Tunis Med; 2000 Feb; 78(2):106-8. PubMed ID: 10894045
[TBL] [Abstract][Full Text] [Related]
17. Molecular biology and genetics of neuroblastoma.
Tay JS
J Singapore Paediatr Soc; 1991; 33(3-4):80-7. PubMed ID: 1812339
[No Abstract] [Full Text] [Related]
18. Presenting features and treatment outcome of 78 Malaysian children with neuroblastoma.
Ng SM; Abdullah WA; Lin HP; Chan LL
Southeast Asian J Trop Med Public Health; 1999 Mar; 30(1):149-53. PubMed ID: 10695803
[TBL] [Abstract][Full Text] [Related]
19. [Cervical neuroblastoma in an infant].
Arvai K; Tóth J; Németh T; Kiss C; Molnár P; Oláh E
Magy Onkol; 2004; 48(1):89-95. PubMed ID: 15105902
[TBL] [Abstract][Full Text] [Related]
20. [Stage IV-S neuroblastoma].
Mancini AF
Pediatr Med Chir; 1984; 6(2):209-12. PubMed ID: 6531245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]